Complete Filing Data
JUPITER NEUROSCIENCES, INC. reported Stockholders Equity of -$7.14 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean JUPITER NEUROSCIENCES, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Net Income Loss | -$2.4M | -$4.8M |
| Research And Development Expense | $492.7K | $954.8K |
| Operating Income Loss | -$3.1M | -$3.9M |
| Operating Expenses | $3.1M | $3.9M |
| Nonoperating Income Expense | $651.7K | -$912.9K |
| Interest Expense Nonoperating | $248.4K | $218.7K |
| General And Administrative Expense | $2.6M | $2.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$2.3M | -$2.3M | -$1.5M | -$591.0K | $313.1K | -$634.1K | -$1.8M | -$832.6K | -$1.7M |
| Research And Development Expense | $816.7K | $759.4K | $466.7K | $91.9K | $101.1K | $98.7K | $239.5K | ||
| Operating Income Loss | -$2.3M | -$2.3M | -$1.5M | -$493.5K | -$557.1K | -$570.7K | -$1.4M | ||
| Operating Expenses | $2.3M | $2.3M | $1.5M | $493.5K | $557.1K | $570.7K | $1.4M | ||
| Nonoperating Income Expense | $9.0K | $11.9K | $9.1K | -$97.5K | $870.2K | -$63.4K | -$332.1K | ||
| Interest Expense Nonoperating | $1.2K | $1.1K | $1.2K | $107.4K | $56.3K | $65.8K | $80.6K | ||
| General And Administrative Expense | $1.5M | $1.5M | $1.1M | $401.6K | $456.0K | $472.0K | $1.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Stockholders Equity | -$7.1M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $64.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.7M | -$36.0K | |
| Retained Earnings Accumulated Deficit | -$23.6M | ||
| Other Assets Noncurrent | $3.8K | ||
| Operating Lease Right Of Use Asset | $116.1K | ||
| Operating Lease Liability Current | $48.2K | ||
| Liabilities Current | $5.8M | ||
| Liabilities And Stockholders Equity | $148.6K | ||
| Liabilities | $5.9M | ||
| Interest Payable Current | $88.0K | ||
| Gains Losses On Extinguishment Of Debt | $857.7K | -$887.9K | |
| Deferred Compensation Liability Current | $1.6M | ||
| Common Stock Value | $2.7K | ||
| Assets Current | $28.7K | ||
| Assets | $148.6K | ||
| Accounts Payable And Accrued Liabilities Current | $546.0K | ||
| Other Assets Current | |||
| Operating Lease Liability Noncurrent | $71.3K | ||
| Amortization Of Debt Discount Premium | $43.3K | $16.7K | |
| Gain Loss On Forgiveness Of Accrued Compensation | $40.0K | ||
| Restricted Stock Issued For Forgiveness Of Accrued Compensation | |||
| Note Payable Related Party Assigned To Note Payable | $266.7K | ||
| Debt Instrument Unamortized Discount Noncurrent | $0.00 | $43.3K | |
| Debt Instrument Unamortized Discount Current | $0.00 | $0.00 | |
| Derivative Liabilities Current | $1.5M | ||
| Convertible Notes Payable Current | $1.6M | ||
| Convertible Long Term Notes Payable | $106.7K | ||
| Stock Issued During Period Value Issuance Of Stock Options For Forgiveness Of Accrued Salaries And Accrued Bonuses | $2.6M | ||
| Stock Issued During Period Value Issuance Of Restricted Stock For Forgiveness Of Accrued Salaries And Accrued Bonuses | $2.2M | ||
| Stock Issued For Exercise Of Options In Exchange For Note Payable Related Parties | $100.0K | ||
| Stock Issued During Period Value Of Issuance Of Stock Options For Forgiveness Of Accrued Salary | $50.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $57.4K | $1.3M | $3.1M | $4.2M | -$5.8M | -$5.4M | -$6.0M | -$5.8M | -$6.3M | -$8.9M | -$8.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $723.8K | $1.9M | $2.7M | $3.8M | $253.00 | $14.9K | $8.3K | $28.5K | $59.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.1M | -$20.2K | |||||||||
| Retained Earnings Accumulated Deficit | -$32.1M | -$29.8M | -$27.6M | -$26.0M | -$24.5M | ||||||
| Other Assets Noncurrent | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | ||||||
| Operating Lease Right Of Use Asset | $34.8K | $46.6K | $58.0K | $69.6K | $81.2K | ||||||
| Operating Lease Liability Current | $34.0K | $46.4K | $50.6K | $50.1K | $49.6K | ||||||
| Liabilities Current | $2.5M | $2.6M | $1.9M | $2.0M | $5.7M | ||||||
| Liabilities And Stockholders Equity | $2.6M | $4.0M | $5.0M | $6.2M | $85.5K | ||||||
| Liabilities | $2.5M | $2.6M | $1.9M | $2.0M | $5.8M | ||||||
| Interest Payable Current | $4.4K | $3.2K | $2.1K | $1.1K | $198.5K | ||||||
| Gains Losses On Extinguishment Of Debt | $951.9K | -$217.5K | |||||||||
| Deferred Compensation Liability Current | $1.8M | $1.9M | $1.4M | $1.4M | $2.0M | ||||||
| Common Stock Value | $3.4K | $3.5K | $3.3K | $3.3K | $3.0K | ||||||
| Assets Current | $1.6M | $2.8M | $3.6M | $4.7M | $514.00 | ||||||
| Assets | $2.6M | $4.0M | $5.0M | $6.2M | $85.5K | ||||||
| Accounts Payable And Accrued Liabilities Current | $478.4K | $574.0K | $282.9K | $396.5K | $663.6K | ||||||
| Other Assets Current | $141.9K | $174.2K | $138.2K | $114.1K | $261.00 | $261.00 | |||||
| Operating Lease Liability Noncurrent | $8.5K | $21.2K | $34.0K | ||||||||
| Amortization Of Debt Discount Premium | $5.0K | ||||||||||
| Gain Loss On Forgiveness Of Accrued Compensation | $40.0K | ||||||||||
| Restricted Stock Issued For Forgiveness Of Accrued Compensation | $60.0K | ||||||||||
| Note Payable Related Party Assigned To Note Payable | |||||||||||
| Debt Instrument Unamortized Discount Noncurrent | $28.3K | ||||||||||
| Debt Instrument Unamortized Discount Current | $0.00 | ||||||||||
| Derivative Liabilities Current | $606.8K | ||||||||||
| Convertible Notes Payable Current | $527.7K | ||||||||||
| Convertible Long Term Notes Payable | $121.7K | ||||||||||
| Stock Issued During Period Value Issuance Of Stock Options For Forgiveness Of Accrued Salaries And Accrued Bonuses | |||||||||||
| Stock Issued During Period Value Issuance Of Restricted Stock For Forgiveness Of Accrued Salaries And Accrued Bonuses | |||||||||||
| Stock Issued For Exercise Of Options In Exchange For Note Payable Related Parties | |||||||||||
| Stock Issued During Period Value Of Issuance Of Stock Options For Forgiveness Of Accrued Salary | $50.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Share Based Compensation | $1.8M | $1.2M |
| Net Cash Provided By Used In Operating Activities | -$3.9M | -$481.0K |
| Increase Decrease In Operating Lease Right Of Use Asset | $1.8K | -$25.00 |
| Increase Decrease In Interest Payable Net | $46.4K | $38.3K |
| Increase Decrease In Deferred Compensation | -$46.9K | $2.1M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$149.5K | $164.9K |
| Proceeds From Notes Payable | $138.5K | $390.0K |
| Net Cash Provided By Used In Financing Activities | $7.7M | $445.0K |
| Proceeds From Issuance Of Common Stock | $150.0K | $55.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | ||
| Increase Decrease In Other Current Assets | $113.8K | -$5.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Share Based Compensation | $421.5K | $60.0K |
| Net Cash Provided By Used In Operating Activities | -$1.1M | -$65.2K |
| Increase Decrease In Operating Lease Right Of Use Asset | $659.00 | $199.00 |
| Increase Decrease In Interest Payable Net | $1.1K | $19.1K |
| Increase Decrease In Deferred Compensation | -$7.4K | $178.8K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$113.6K | $13.2K |
| Proceeds From Notes Payable | $45.0K | |
| Net Cash Provided By Used In Financing Activities | $45.0K | |
| Proceeds From Issuance Of Common Stock | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $24.1K | |
| Increase Decrease In Other Current Assets | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition | $60.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2021 | FY2019 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 28.8M | 26.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 28.8M | 26.4M | ||
| Earnings Per Share Diluted | $-0.08 | $-0.18 | ||
| Earnings Per Share Basic | $-0.08 | $-0.18 | ||
| Common Stock Shares Authorized | 125.0M | 125.0M | 45.0M | 25.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 5.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | |||
| Common Stock Shares Outstanding | 26.5M | |||
| Common Stock Shares Issued | 26.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 34.0M | 33.2M | 33.1M | 31.1M | 27.5M | 26.5M | 26.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 34.0M | 33.2M | 33.1M | 31.1M | 30.6M | 26.5M | 26.4M | ||
| Earnings Per Share Diluted | $-0.07 | $-0.07 | $-0.05 | $-0.02 | $0.01 | $-0.02 | $-0.07 | ||
| Earnings Per Share Basic | $-0.07 | $-0.07 | $-0.05 | $-0.02 | $0.01 | $-0.02 | $-0.07 | ||
| Common Stock Shares Authorized | 125.0M | 125.0M | 125.0M | 125.0M | 125.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 34.3M | 34.8M | 33.1M | 33.1M | 30.1M | ||||
| Common Stock Shares Issued | 34.3M | 34.8M | 33.1M | 33.1M | 30.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Stock Granted During Period Value Sharebased Compensation | $1.8M | $1.2M |
| Investment Income Interest | $5.6K | $482.00 |
| Gain Loss On Derivative Instruments Net Pretax | -$53.3K | $148.8K |
| Interest Paid Net | $147.8K | $28.1K |
| Stock Issued During Period Value New Issues | $150.0K | $55.0K |
| Additional Paid In Capital | $17.8M | |
| Prepaid Expense Noncurrent | ||
| Prepaid Expense Current | ||
| Other Income | $90.0K | $44.5K |
| Stock Options Issued For Forgiveness Of Salary | $50.0K | $2.6M |
| Restricted Stock Issued For Forgiveness Of Salary | $10.0K | $2.2M |
| Gain Loss On Amortization Of Prepaid Contracts | $54.6K | |
| Stock Issued During Period Value Other | $9.7M | |
| Sale Of Stock Consideration Received On Transaction | ||
| Stock Issued1 | $150.0K | |
| Stock Issued For Conversion Of Notes | $636.9K | |
| Stock Issued During Period Value Stock Options Exercised | $100.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock Granted During Period Value Sharebased Compensation | $792.7K | $462.5K | $421.5K | $195.1K | $277.0K | $355.3K | $253.0K | $350.9K | $381.5K | |
| Investment Income Interest | $10.2K | $13.1K | $10.4K | $23.00 | $53.00 | $62.00 | $161.00 | |||
| Gain Loss On Derivative Instruments Net Pretax | $9.9K | -$25.4K | -$37.7K | -$34.1K | ||||||
| Interest Paid Net | $146.00 | $28.1K | ||||||||
| Stock Issued During Period Value New Issues | $212.6K | $66.0K | $75.0K | |||||||
| Additional Paid In Capital | $32.1M | $31.1M | $30.6M | $30.2M | $18.8M | |||||
| Prepaid Expense Noncurrent | $905.3K | $1.1M | $1.3M | $1.5M | ||||||
| Prepaid Expense Current | $766.7K | $766.7K | $766.7K | $766.7K | ||||||
| Other Income | $40.0K | |||||||||
| Stock Options Issued For Forgiveness Of Salary | ||||||||||
| Restricted Stock Issued For Forgiveness Of Salary | ||||||||||
| Gain Loss On Amortization Of Prepaid Contracts | $189.0K | |||||||||
| Stock Issued During Period Value Other | $30.0K | $25.0K | ||||||||
| Sale Of Stock Consideration Received On Transaction | $75.0K | |||||||||
| Stock Issued1 | ||||||||||
| Stock Issued For Conversion Of Notes | ||||||||||
| Stock Issued During Period Value Stock Options Exercised |
Most recent annual filing with the SEC: March 28, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.